Literature DB >> 25541477

The natural history of molluscum contagiosum in children.

Alexander K C Leung1.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25541477     DOI： 10.1016/S1473-3099(14)71061-8

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN： 1473-3099            Impact factor:   25.071


× No keyword cloud information.
  7 in total

Review 1.  Childhood Langerhans cell histiocytosis: a disease with many faces.

Authors:  Alexander K C Leung; Joseph M Lam; Kin Fon Leong
Journal:  World J Pediatr       Date:  2019-08-28       Impact factor: 2.764

2.  Safety and Efficacy of VP-102 (Cantharidin, 0.7% w/v) in Molluscum Contagiosum by Body Region: Post hoc Pooled Analyses from Two Phase III Randomized Trials.

Authors:  Lawrence F Eichenfield; Pearl Kwong; Mercedes E Gonzalez; Albert Yan; Pieter D'Arnaud; Patrick Burnett; Melissa Olivadoti
Journal:  J Clin Aesthet Dermatol       Date:  2021-10

Review 3.  New Developing Treatments for Molluscum Contagiosum.

Authors:  Francesco Lacarrubba; Giuseppe Micali; Andrea Calogero Trecarichi; Enrica Quattrocchi; Giuseppe Monfrecola; Anna Elisa Verzì
Journal:  Dermatol Ther (Heidelb)       Date:  2022-10-14

Review 4.  Gianotti-Crosti syndrome (papular acrodermatitis of childhood) in the era of a viral recrudescence and vaccine opposition.

Authors:  Alexander K C Leung; Consolato Maria Sergi; Joseph M Lam; Kin Fon Leong
Journal:  World J Pediatr       Date:  2019-05-27       Impact factor: 9.186

Review 5.  Penile warts: an update on their evaluation and management.

Authors:  Alexander Kc Leung; Benjamin Barankin; Kin Fon Leong; Kam Lun Hon
Journal:  Drugs Context       Date:  2018-12-19

Review 6.  Dermatology: how to manage acne vulgaris.

Authors:  Alexander Kc Leung; Benjamin Barankin; Joseph M Lam; Kin Fon Leong; Kam Lun Hon
Journal:  Drugs Context       Date:  2021-10-11

7.  Safety and Efficacy of VP-102, a Proprietary, Drug-Device Combination Product Containing Cantharidin, 0.7% (w/v), in Children and Adults With Molluscum Contagiosum: Two Phase 3 Randomized Clinical Trials.

Authors:  Lawrence F Eichenfield; Wendy McFalda; Bradford Brabec; Elaine Siegfried; Pearl Kwong; Mark McBride; Jayson Rieger; Cynthia Willson; Matthew Davidson; Patrick Burnett
Journal:  JAMA Dermatol       Date:  2020-12-01       Impact factor: 10.282
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.